Corvus Pharmaceuticals, Inc. (CRVS)
11.50
-0.71
(-5.81%)
USD |
NASDAQ |
May 19, 16:00
11.47
-0.03
(-0.26%)
After-Hours: 07:43
Corvus Pharmaceuticals Shareholders Equity (Quarterly) : 240.68M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
| Savara, Inc. | 176.04M |
| Biogen, Inc. | 18.65B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 253.20M |
| Total Liabilities (Quarterly) | 12.52M |
| Debt to Equity Ratio | 0.0035 |
| Current Ratio | 19.81 |
| Net Debt Paydown Yield | 0.00% |